Innovative ETFs Content Hub Consider Getting Bond Exposure for the Long Haul By Ben HernandezMay 4, 2020
Innovative ETFs Content Hub The Hedge Fund Kids are Alright Despite Pandemic By Ben HernandezMay 1, 2020
Innovative ETFs Content Hub Investor Demand is Strong for Boeing’s Latest Bond Offering By Ben HernandezMay 1, 2020
Innovative ETFs Content Hub Dividends Have Increased Importance in Today’s Market By Ben HernandezApril 30, 2020
Innovative ETFs Content Hub Significant Risks Lie Ahead for Emerging Markets By Ben HernandezApril 30, 2020
Innovative ETFs Content Hub U.S. Stock ETFs Rally on Coronavirus Treatment Hopes By Max ChenApril 29, 2020
Innovative ETFs Content Hub Bonds in the Strongest Emerging Market Countries Are Seeing Investor Interest By Ben HernandezApril 29, 2020
Innovative ETFs Content Hub Improving Economic Conditions Could Push 10-Year Treasury Yield Higher By Ben HernandezApril 29, 2020
Innovative ETFs Content Hub U.S. Stock ETFs Are Mixed Ahead of Big Tech Earnings Week By Max ChenApril 28, 2020
Innovative ETFs Content Hub Delta Joins High Yield Bond Party as Coronavirus Batters Airline Industry By Ben HernandezApril 28, 2020
Innovative ETFs Content Hub Bank of Japan will Join Other Central Banks in Corporate Bond Buying By Ben HernandezApril 28, 2020
Innovative ETFs Content Hub US Core Capital Goods Rise in March, While Durable Goods Fall By Ben HernandezApril 27, 2020
Innovative ETFs Content Hub ETFs to Watch as Zoom, Facebook Battle for Video Chat Market Share By Ben HernandezApril 27, 2020
Innovative ETFs Content Hub U.S. Stock ETFs Eke Out Modest Gains After a Tough Week By Max ChenApril 24, 2020
Innovative ETFs Content Hub Will the Bank of Japan Follow U.S. Fed’s Bond Buying Strategy? By Ben HernandezApril 24, 2020
Innovative ETFs Content Hub Strong Demand for Netflix Bonds Spurs Low Yield Offering By Ben HernandezApril 24, 2020
Innovative ETFs Content Hub Stay-At-Home Measures Are a Boon for Video Game ETFs By Max ChenApril 23, 2020
Innovative ETFs Content Hub U.S. Stock ETFs Pare Early Gains on Poor Coronavirus Drug Trial By Max ChenApril 23, 2020
